퓨젠바이오
1 known investors
Fugen Bio (퓨젠바이오) develops patented biomaterials, notably its CLEPS® ingredient, and sells consumer health and beauty products such as the Cellab biogenic essence and Cellna, a blood-sugar and insulin-resistance care product with clinically tested effects. The company operates in the biotech-based cosmetics and health supplement space, primarily in South Korea.
Investors · 1
Frequently asked questions
- What does 퓨젠바이오 do?
- Fugen Bio (퓨젠바이오) develops patented biomaterials, notably its CLEPS® ingredient, and sells consumer health and beauty products such as the Cellab biogenic essence and Cellna, a blood-sugar and insulin-resistance care product with clinically tested effects. The company operates in the biotech-based cosmetics and health supplement space, primarily in South Korea.
- Who are 퓨젠바이오's investors?
- 퓨젠바이오's investors include Solidus Investment.